Carbenoxolone in HIV-related oropharyngeal ulceration.
Poswillo
D
D
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D002229:Carbenoxolone / Q000008:administration & dosage*; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives*; D006801:Humans; D009067:Mouthwashes / Q000627:therapeutic use; D009960:Oropharynx; D010608:Pharyngeal Diseases / Q000188:drug therapy*; D014456:Ulcer / Q000188:drug therapy
D009067:Mouthwashes; D002229:Carbenoxolone; D006034:Glycyrrhetinic Acid